
Roham Zamanian
652 posts

Roham Zamanian
@docroham
Professor of Medicine ; Director Adult Pulmonary Hypertension Program ; Associate Director Vera Moulton Wall Center; clinical trialist ; photographer.





Are we ready for “disease modification”? We got the scoop! Check out the paper-available today online.



What does “disease modification” mean in #PulmonaryArterialHypertension? Honoured to be part of this perspective in @ATSBlueEditor led by @Viniciodjperez & @docroham atsjournals.org/doi/abs/10.116… @VApccm @BogaardHarm @mpsotka @PHACanada @PHAssociation @PVRI @UAlberta_DoM

The PVRI is deeply saddened by the loss of Dr John Newman, a cherished member of the Pulmonary Vascular Disease community. His dedication and expertise have left an indelible mark on our field. Sending heartfelt condolences to his loved ones and colleagues during this time.




























